Loring Wolcott & Coolidge Fiduciary Advisors LLP Edwards Lifesciences Corp Transaction History
Loring Wolcott & Coolidge Fiduciary Advisors LLP
- $11.1 Billion
- Q3 2024
A detailed history of Loring Wolcott & Coolidge Fiduciary Advisors LLP transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Loring Wolcott & Coolidge Fiduciary Advisors LLP holds 59,098 shares of EW stock, worth $4.17 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
59,098
Previous 105,844
44.16%
Holding current value
$4.17 Million
Previous $9.78 Million
60.12%
% of portfolio
0.04%
Previous 0.09%
Shares
31 transactions
Others Institutions Holding EW
# of Institutions
1,349Shares Held
456MCall Options Held
9.76MPut Options Held
3.92M-
Vanguard Group Inc Valley Forge, PA62.6MShares$4.41 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY51MShares$3.59 Billion0.11% of portfolio
-
Wellington Management Group LLP Boston, MA31.5MShares$2.22 Billion0.37% of portfolio
-
State Street Corp Boston, MA26.3MShares$1.85 Billion0.07% of portfolio
-
Geode Capital Management, LLC Boston, MA13.5MShares$953 Million0.07% of portfolio
About Edwards Lifesciences Corp
- Ticker EW
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 618,259,968
- Market Cap $43.6B
- Description
- Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...